Prolintane

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Prolintane
Prolintane.svg
Prolintane3d.png
Clinical data
Routes of
administration
oral, intranasal, rectal
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
ECHA InfoCard 100.007.077
Chemical and physical data
Formula C15H23N
Molar mass 217.35 g/mol
3D model (Jmol)
 NYesY (what is this?)  (verify)

Prolintane (Catovit, Promotil, Villescon) is a stimulant[1] and norepinephrine-dopamine reuptake inhibitor developed in the 1950s.[2] It is closely related in chemical structure to other drugs such as pyrovalerone, MDPV, and propylhexedrine and it has a similar mechanism of action.[3] Many cases of prolintane abuse have been reported.[4]

See also[edit]

References[edit]

  1. ^ Hollister, L. E.; Gillespie, H. K. (March–April 1970). "A New Stimulant, Prolintane Hydrochloride, Compared with Dextroamphetamine in Fatigued Volunteers". The Journal of Clinical Pharmacology. 10 (2): 103–109. doi:10.1177/009127007001000205. PMID 4392006. 
  2. ^ GB Patent 807835
  3. ^ Nicholson, A. N.; Stone, B. M.; Jones, M. M. (November 1980). "Wakefullness and reduced rapid eye movement sleep: studies with prolintane and pemoline.". British Journal of Clinical Pharmacology. 10 (5): 465–472. doi:10.1111/j.1365-2125.1980.tb01790.x. PMC 1430138Freely accessible. PMID 7437258. 
  4. ^ Kyle, P. B.; Daley, W. P. (September 2007). "Domestic Abuse of the European Rave Drug Prolintane". Journal of Analytical Toxicology. 31 (7): 415–418. doi:10.1093/jat/31.7.415. PMID 17725890.